Modeling the Conformational Changes Underlying Channel Opening in CFTR

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Rahman, Kazi S ^a   Cui, Guiying ^b   Harvey, Stephen C ^a   McCarty, Nael A ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ION CHANNEL;

ARTICLE; CHANNEL GATING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; NUCLEOTIDE BINDING SITE; PREDICTION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN TARGETING; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS;

ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; ION CHANNEL GATING; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR DYNAMICS SIMULATION; MUTANT PROTEINS; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84884699027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074574     Document Type: Article

References (74)

1. Dean M, Hamon Y, Chimini G, (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42: 1007-1017.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
3. Quinton PM, (1990) Cystic fibrosis: a disease in electrolyte transport. FASEB J 4: 2709-2717.
4. Anderson M, Gregory R, Thompson S, Souza D, Paul S, et al. (1991) Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253: 202-205 doi:10.1126/science.1712984.
5. Pilewski J, Frizzell R, (1999) Role of CFTR in airway disease. Physiological Reviews 79: S215-S255.
6. Field M, Semrad C, (1993) Toxigenic diarrheas, congenital diarrheas, and cystic fibrosis: disorders of intestinal ion transport. Annu Rev Physiol 55: 631-655.
7. Higgins CF, (1995) The ABC of channel regulation. Cell 82: 693-696.
8. Higgins CF, Linton KJ, (2004) The ATP switch model for ABC transporters. Nat Struct Mol Biol 11: 918-926 doi:10.1038/nsmb836.
9. Basso C, Vergani P, Nairn AC, Gadsby DC, (2003) Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating. J Gen Physiol 122: 333-348 doi:10.1085/jgp.200308798.
10. Jordan IK, Kota KC, Cui G, Thompson CH, McCarty NA, (2008) Evolutionary and functional divergence between the cystic fibrosis transmembrane conductance regulator and related ATP-binding cassette transporters. Proc Natl Acad Sci U S A 105: 18865-18870 doi:10.1073/pnas.0806306105.
11. Lewis HA, Buchanan SG, Burley SK, Conners K, Dickey M, et al. (2003) Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J 23: 282-293 doi:10.1038/sj.emboj.7600040.
12. Lewis HA, Zhao X, Wang C, Sauder JM, Rooney I, et al. (2005) Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem 280: 1346-1353 doi:10.1074/jbc.M410968200.
13. Lewis HA, Wang C, Zhao X, Hamuro Y, Conners K, et al. (2010) Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry. J Mol Biol 396: 406-430 doi:10.1016/j.jmb.2009.11.051.
14. Rosenberg MF, O'Ryan LP, Hughes G, Zhao Z, Aleksandrov LA, et al. (2011) The cystic fibrosis transmembrane conductance regulator (CFTR): three-dimensional structure and localization of a channel gate. J Biol Chem 286: 42647-42654 doi:10.1074/jbc.M111.292268.
15. Baker JMR, Hudson RP, Kanelis V, Choy W-Y, Thibodeau PH, et al. (2007) CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struct Mol Biol 14: 738-745 doi:10.1038/nsmb1278.
16. Vergani P, Lockless SW, Nairn AC, Gadsby DC, (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433: 876-880 doi:10.1038/nature03313.
17. Bai Y, Li M, Hwang T-C, (2011) Structural basis for the channel function of a degraded ABC transporter, CFTR (ABCC7). J Gen Physiol 138: 495-507 doi:10.1085/jgp.201110705.
18. Dawson RJP, Locher KP, (2006) Structure of a bacterial multidrug ABC transporter. Nature 443: 180-185 doi:10.1038/nature05155.
19. Serohijos AWR, Hegedus T, Aleksandrov AA, He L, Cui L, et al. (2008) Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A 105: 3256-3261 doi:10.1073/pnas.0800254105.
20. Mornon J-P, Lehn P, Callebaut I, (2008) Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces. Cell Mol Life Sci 65: 2594-2612 doi:10.1007/s00018-008-8249-1.
21. Alexander CS, Ivetac A, Liu X, Norimatsu Y, Serrano JR, et al. (2009) Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore. Biochemistry 48: 10078-10088 doi:10.1021/bi901314c.
22. Mornon J-P, Lehn P, Callebaut I, (2009) Molecular models of the open and closed states of the whole human CFTR protein. Cell Mol Life Sci 66: 3469-3486 doi:10.1007/s00018-009-0133-0.
23. Norimatsu Y, Ivetac A, Alexander CS, Kirkham J, O'Donnell N, et al. (2012) Cystic fibrosis transmembrane conductance regulator: a molecular model defines the architecture of the anion conduction path and locates a "bottleneck" in the pore. Biochemistry 51: 2199-2212 doi:10.1021/bi201888a.
24. Dalton J, Kalid O, Schushan M, Ben-Tal N, Villà-Freixa J, (2012) New model of cystic fibrosis transmembrane conductance regulator proposes active channel-like conformation. J Chem Inf Model 52: 1842-1853 doi:10.1021/ci2005884.
25. Ward A, Reyes CL, Yu J, Roth CB, Chang G, (2007) Flexibility in the ABC transporter MsbA: Alternating access with a twist. Proc Natl Acad Sci U S A 104: 19005-19010 doi:10.1073/pnas.0709388104.
26. Furukawa-Hagiya T, Furuta T, Chiba S, Sohma Y, Sakurai M, (2013) The power stroke driven by ATP binding in CFTR as studied by molecular dynamics simulations. J Phys Chem B 117: 83-93 doi:10.1021/jp308315w.
27. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, et al. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323: 1718-1722 doi:10.1126/science.1168750.
28. Sali A, Blundell TL, (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815 doi:10.1006/jmbi.1993.1626.
29. Cotten JF, Welsh MJ, (1999) Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR. Evidence for disruption of a salt bridge. J Biol Chem 274: 5429-5435.
30. Cui G, Zhang Z-R, O'Brien ARW, Song B, McCarty NA, (2008) Mutations at arginine 352 alter the pore architecture of CFTR. J Membr Biol 222: 91-106 doi:10.1007/s00232-008-9105-9.
31. Zhang Z-R, Zeltwanger S, McCarty NA, (2000) Direct comparison of NPPB and DPC as probes of CFTR expressed in Xenopus oocytes. J Membr Biol 175: 35-52.
32. McCarty NA, Zhang Z-R, (2001) Identification of a region of strong discrimination in the pore of CFTR. Am J Physiol Lung Cell Mol Physiol 281: L852-L867.
33. Smith SS, Liu X, Zhang Z-R, Sun F, Kriewall TE, et al. (2001) CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction. J Gen Physiol 118: 407-431.
34. Gong X, Linsdell P, (2003) Molecular determinants and role of an anion binding site in the external mouth of the CFTR chloride channel pore. J Physiol 549: 387-397 doi:10.1113/jphysiol.2002.038232.
35. Gong X, Burbridge SM, Cowley EA, Linsdell P, (2002) Molecular determinants of Au (CN)2- binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl- channel pore. J Physiol 540: 39-47.
36. Gupta J, Evagelidis A, Hanrahan JW, Linsdell P, (2001) Asymmetric structure of the cystic fibrosis transmembrane conductance regulator chloride channel pore suggested by mutagenesis of the twelfth transmembrane region. Biochemistry 40: 6620-6627.
37. Liu X, Zhang Z-R, Fuller MD, Billingsley J, McCarty NA, et al. (2004) CFTR: a cysteine at position 338 in TM6 senses a positive electrostatic potential in the pore. Biophys J 87: 3826-3841 doi:10.1529/biophysj.104.050534.
38. Aubin CNS, Linsdell P, (2006) Positive charges at the intracellular mouth of the pore regulate anion conduction in the CFTR chloride channel. J Gen Physiol 128: 535-545 doi:10.1085/jgp.200609516.
39. Beck EJ, Yang Y, Yaemsiri S, Raghuram V, (2008) Conformational changes in a pore-lining helix coupled to cystic fibrosis transmembrane conductance regulator channel gating. J Biol Chem 283: 4957-4966 doi:10.1074/jbc.M702235200.
40. Fatehi M, Linsdell P, (2008) State-dependent access of anions to the cystic fibrosis transmembrane conductance regulator chloride channel pore. J Biol Chem 283: 6102-6109 doi:10.1074/jbc.M707736200.
41. Serrano JR, Liu X, Borg ER, Alexander CS, Shaw CF, et al. (2006) CFTR: Ligand exchange between a permeant anion ([Au(CN)2]-) and an engineered cysteine (T338C) blocks the pore. Biophys J 91: 1737-1748 doi:10.1529/biophysj.105.078899.
42. Bai Y, Li M, Hwang T-C, (2010) Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation. J Gen Physiol 136: 293-309 doi:10.1085/jgp.201010480.
43. Cui G, Song B, Turki HW, McCarty NA, (2012) Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers. Pflugers Arch 463: 405-418 doi:10.1007/s00424-011-1035-1.
44. Zhou J-J, Li M-S, Qi J, Linsdell P, (2010) Regulation of conductance by the number of fixed positive charges in the intracellular vestibule of the CFTR chloride channel pore. J Gen Physiol 135: 229-245 doi:10.1085/jgp.200910327.
45. Qian F, Hiani El Y, Linsdell P, (2011) Functional arrangement of the 12th transmembrane region in the CFTR chloride channel pore based on functional investigation of a cysteine-less CFTR variant. Pflugers Arch 462: 559-571 doi:10.1007/s00424-011-0998-2.
46. Chen EY, Bartlett MC, Loo TW, Clarke DM, (2004) The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 279: 39620-39627 doi:10.1074/jbc.M407887200.
47. Wallin E, Tsukihara T, Yoshikawa S, Heijne GV, Elofsson A, (1997) Architecture of helix bundle membrane proteins: An analysis of cytochrome c oxidase from bovine mitochondria. Protein Sci 6: 808-815 doi:10.1002/pro.5560060407.
48. Marcus Y (1997) Ion Properties. New York: Marcel Dekker. 259 p.
49. Linsdell P, (2006) Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. Exp Physiol 91: 123-129 doi:10.1113/expphysiol.2005.031757.
50. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26: 283-291 doi:10.1107/S0021889892009944.
51. Zhang Z-R, Cui G, Liu X, Song B, Dawson DC, et al. (2005) Determination of the functional unit of the cystic fibrosis transmembrane conductance regulator chloride channel. One polypeptide forms one pore. J Biol Chem 280: 458-468 doi:10.1074/jbc.M409626200.
52. Zhang Z-R, Song B, McCarty NA, (2005) State-dependent chemical reactivity of an engineered cysteine reveals conformational changes in the outer vestibule of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 280: 41997-42003 doi:10.1074/jbc.M510242200.
53. Norimatsu Y, Ivetac A, Alexander CS, O'Donnell N, Frye L, et al. (2012) Locating a plausible binding site for an open-channel blocker, GlyH-101, in the pore of the cystic fibrosis transmembrane conductance regulator. Mol Pharmacol 82: 1042-1055 doi:10.1124/mol.112.080267.
54. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935 doi:10.1063/1.445869.
55. Grosman C, Zhou M, Auerbach A, (2000) Mapping the conformational wave of acetylcholine receptor channel gating. Nature 403: 773-776.
56. Hohl M, Briand C, Grütter MG, Seeger MA, (2012) Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation. Nat Struct Mol Biol 19: 395-402 doi:10.1038/nsmb.2267.
57. Cui G, Freeman CS, Knotts T, Prince CZ, Kuang C, et al. (2013) Two salt bridges differentially contribute to the maintenance of cystic fibrosis transmembrane conductance regulator (CFTR) channel function. J Biol Chem 288: 20758-20767 doi:10.1074/jbc.M113.476226.
58. Smart OS, Neduvelil JG, Wang X, Wallace BA, Sansom MSP, (1996) HOLE: A program for the analysis of the pore dimensions of ion channel structural models. J Mol Graph 14: 354-360 doi:10.1016/S0263-7855(97)00009-X.
59. Cystic Fibrosis Mutation Database (n.d.) Cystic Fibrosis Mutation Database. Available: http://www.genet.sickkids.on.ca/cftr/app. Accessed 2012 Dec 7.
60. Fuller MD, Zhang Z-R, Cui G, McCarty NA, (2005) The block of CFTR by scorpion venom is state-dependent. Biophys J 89: 3960-3975 doi:10.1529/biophysj.105.060731.
61. Kogan I, Ramjeesingh M, Li C, Kidd JF, Wang Y, et al. (2003) CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J 22: 1981-1989 doi:10.1093/emboj/cdg194.
62. Weng J, Fan KN, Wang W, (2012) The conformational transition pathways of ATP-binding cassette transporter BtuCD revealed by targeted molecular dynamics simulation. PLoS One 7: e30465 doi:10.1371/journal.pone.0030465.
63. St-Pierre J-F, Bunker A, Róg T, Karttunen M, Mousseau N, (2012) Molecular dynamics simulations of the bacterial ABC transporter SAV1866 in the closed form. J Phys Chem B 116: 2934-2942 doi:10.1021/jp209126c.
64. Csanády L, Nairn AC, Gadsby DC, (2006) Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle. J Gen Physiol 128: 523-533 doi:10.1085/jgp.200609558.
65. Liu X, Dawson DC, (2011) Cystic fibrosis transmembrane conductance regulator: temperature-dependent cysteine reactivity suggests different stable conformers of the conduction pathway. Biochemistry 50: 10311-10317 doi:10.1021/bi201176q.
66. Khafizov K, Staritzbichler R, Stamm M, Forrest LR, (2010) A study of the evolution of inverted-topology repeats from LeuT-fold transporters using AlignMe. Biochemistry 49: 10702-10713 doi:10.1021/bi101256x.
67. Kyte J, Doolittle RF, (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
68. McGuffin LJ, Bryson K, Jones DT, (2000) The PSIPRED protein structure prediction server. Bioinformatics 16: 404-405.
69. Viklund H, Elofsson A, (2008) OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar. Bioinformatics 24: 1662-1668.
70. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38, 27-28.
71. Schriml LM, Dean M, (2000) Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. Genomics 64: 24-31 doi:10.1006/geno.1999.6102.
72. Lomize MA, Lomize AL, Pogozheva ID, Mosberg HI, (2006) OPM: orientations of proteins in membranes database. Bioinformatics 22: 623-625 doi:10.1093/bioinformatics/btk023.
73. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, et al. (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26: 1781-1802 doi:10.1002/jcc.20289.
74. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, et al. (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4: 187-217 doi:10.1002/jcc.540040211.